Plain-English translation of NCT06700811 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether a —a special high-fat, low-carbohydrate diet given as a medical formula—can help prevent epileptic spasms in very young babies with genetic epilepsies. Epileptic spasms are a severe and difficult-to-treat type of seizure that can affect development. The researchers want to see if starting this diet early can stop these spasms from developing or make them easier to treat with medicine.
Epileptic spasms affect more than half of babies with certain genetic forms of epilepsy and can interfere with development. While this treatment has helped older children and infants with hard-to-control seizures, doctors don't yet know whether starting it earlier—even before spasms develop—might prevent them altogether and improve outcomes.
You likely qualify if…
You likely don't qualify if…
Your baby will receive a special ketogenic formula through bottle feeding or a feeding tube, starting within 6 weeks of enrollment. You'll bring your baby in for regular EEG monitoring (brain wave tests) every 6 weeks to see how the diet is working. The diet will continue until your baby is 12 months old or for 3 months after epileptic spasms develop, whichever comes first. Your family will work closely with the research team to maintain the diet and attend all monitoring visits.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States